BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15554908)

  • 1. Changes in renal haemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases.
    Caron N; El Hajjam A; Declèves AE; Joly E; Falck JR; Kramp R
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):683-90. PubMed ID: 15554908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of arachidonic acid epoxidation in vivo.
    Brand-Schieber E; Falck JF; Schwartzman M
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):655-72. PubMed ID: 11192939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel.
    Gross ER; Nithipatikom K; Hsu AK; Peart JN; Falck JR; Campbell WB; Gross GJ
    J Mol Cell Cardiol; 2004 Dec; 37(6):1245-9. PubMed ID: 15572055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative contributions of cyclooxygenase- and cytochrome P450 omega-hydroxylase-dependent pathways to hypoxic dilation of skeletal muscle resistance arteries.
    Frisbee JC; Roman RJ; Krishna UM; Falck JR; Lombard JH
    J Vasc Res; 2001; 38(4):305-14. PubMed ID: 11455201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal functional effects of endothelins: dependency on cytochrome P450-derived arachidonate metabolites.
    Oyekan AO; McAward K; McGiff JC
    Biol Res; 1998; 31(3):209-15. PubMed ID: 9830508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II modulates ion transport in rat proximal tubules through CYP metabolites.
    Sánchez-Mendoza A; López-Sánchez P; Vázquez-Cruz B; Rios A; Martínez-Ayala S; Escalante B
    Biochem Biophys Res Commun; 2000 Jun; 272(2):423-30. PubMed ID: 10833430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid inhibits Na⁺-K⁺-ATPase via cytochrome P-450, lipoxygenase and protein kinase C-dependent pathways in sheep pulmonary artery.
    Singh TU; Choudhury S; Parida S; Maruti BS; Mishra SK
    Vascul Pharmacol; 2012; 56(1-2):84-90. PubMed ID: 22155164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P450 arachidonate metabolites mediate bradykinin-dependent inhibition of NaCl transport in the rat thick ascending limb.
    Grider JS; Falcone JC; Kilpatrick EL; Ott CE; Jackson BA
    Can J Physiol Pharmacol; 1997 Feb; 75(2):91-6. PubMed ID: 9114929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ATP on rat renal haemodynamics and excretion: role of sodium intake, nitric oxide and cytochrome P450.
    Dobrowolski L; Walkowska A; Kompanowska-Jezierska E; Kuczeriszka M; Sadowski J
    Acta Physiol (Oxf); 2007 Jan; 189(1):77-85. PubMed ID: 17280559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid omega-hydroxylase, on renal function in rats.
    Zou AP; Ma YH; Sui ZH; Ortiz de Montellano PR; Clark JE; Masters BS; Roman RJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):474-81. PubMed ID: 8301590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo.
    Chu ZM; Croft KD; Kingsbury DA; Falck JR; Reddy KM; Beilin LJ
    Clin Sci (Lond); 2000 Mar; 98(3):277-82. PubMed ID: 10677385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors.
    Wang MH; Brand-Schieber E; Zand BA; Nguyen X; Falck JR; Balu N; Schwartzman ML
    J Pharmacol Exp Ther; 1998 Mar; 284(3):966-73. PubMed ID: 9495856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles.
    Kohagura K; Arima S; Endo Y; Chiba Y; Ito O; Abe M; Omata K; Ito S
    Hypertens Res; 2001 Sep; 24(5):551-7. PubMed ID: 11675950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR.
    Pomposiello SI; Carroll MA; Falck JR; McGiff JC
    Hypertension; 2001 Mar; 37(3):887-93. PubMed ID: 11244013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome p450-dependent metabolites of arachidonic acid and renal function in the rat.
    Oyekan AO
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):581-6. PubMed ID: 10901386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P-450 monooxygenases in control of renal haemodynamics and arterial pressure in anaesthetized rats.
    Kuczeriszka M; Badzyńska B; Kompanowska-Jezierska E
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():179-85. PubMed ID: 17244949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained increase in arterial blood pressure and vascular resistance induced by infusion of arachidonic acid in rats.
    Kirkebø A; Haugan A; Mesteig K
    Acta Physiol Scand; 2000 Sep; 170(1):1-9. PubMed ID: 10971217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prostanoids and 20-HETE in mediating oxygen-induced constriction of skeletal muscle resistance arteries.
    Frisbee JC; Krishna UM; Falck JR; Lombard JH
    Microvasc Res; 2001 Nov; 62(3):271-83. PubMed ID: 11678630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome p450-derived arachidonate metabolites.
    Oyekan AO; McGiff JC
    Br J Pharmacol; 1998 Nov; 125(5):1065-73. PubMed ID: 9846646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of NO and COX pathways in mediation of adenosine A1 receptor-induced renal vasoconstriction.
    Walkowska A; Dobrowolski L; Kompanowska-Jezierska E; Sadowski J
    Exp Biol Med (Maywood); 2007 May; 232(5):690-4. PubMed ID: 17463166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.